Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion

Bone Marrow Transplantation

Volumn 19, Issue 8, 1997, Pages 845-847

  Woo, M H ^a   Ippoliti, C ^a,b   Bruton, J ^a   Mehra, R ^a   Champlin, R ^a   Przepiorka, D ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Autologous PBSC transplantation; Carmustine; Circumoral paresthesia; Flushing; Headache

Indexed keywords

ANALGESIC AGENT; BENZODIAZEPINE DERIVATIVE; CARMUSTINE; CORTICOSTEROID; NITROSOUREA DERIVATIVE; OPIATE AGONIST;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; FLUSHING; HEADACHE; HUMAN; METASTASIS; PARESTHESIA; PERIPHERAL BLOOD STEM CELL; PREMEDICATION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0030978369     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700743     Document Type: Article

References (10)

1. Peters WP, Ross M, Vredenburgh JJ et al. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 1993; 11: 1132-1143.
2. Peters WP, Shpall EJ, Jones RB et al. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 1988; 6: 1368-1376.
3. Takvorian T, Parker LM, Hochberg FH, Canellos GP. Autologous bone-marrow transplantation: host effects of high-dose BCNU. J Clin Oncol 1983; 1: 610-620.
4. Peters WP, Eder JP, Henner WD et al. High-dose combination alkylating agents with bone marrow support: a phase I trial. J Clin Oncol 1986; 4: 646-654.
5. Ayash LJ, Hunt M, Antman K. Hepatic occlusive disease in autologous bone marrow transplantation of solid tumor and lymphomas. J Clin Oncol 1990; 8: 1699-1706.
6. McIntyre RE, Magidson JG, Austin GE, Gale RP. Fatal venoocclusive disease of the liver following high-dose 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and autologous bone marrow transplantation. Am J Clin Pathol 1981; 75: 614-617.
7. Burger PC, Kamenar E, Schold SC et al. Encephalopathy following high-dose BCNU therapy. Cancer 1981; 48: 1318-1327.
8. Philips GL, Wolff SN, Fay JW et al. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma. J Clin Oncol 1986; 4: 639-645.
9. Rabinowitz J, Petros WP, Stuart AR, Peters WP. Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support. Blood 1993; 81: 2452-2459.
10. Arena PJ. Oropharyngeal sensation associated with rapid intravenous administration of cyclophosphamide (NSC-26271). Cancer Chemother Rep 1972; 56: 779-780.